The Abbott BinaxNOW COVID-19 test is a low-cost healthcare solution from the company that takes aim at fast, effective virus testing to help contain the spread. The test is characterized by its credit card-sized design that uses specimens taken from a nasal swap in order to determine whether or not a person has the virus.
The test is capable of delivering 97.1% and 98.5% accuracy rates for positive and negative results respectively, and works with the company's Novice app to provide users with a temporary health pass to let others know their status. The Abbott BinaxNOW COVID-19 test is priced at just $5 and is expected to be shipped in the tens of millions in September with 50 million per month expected to start being produced by early October.
Low-Cost Virus Test Kits
The Abbott BinaxNOW COVID-19 Test Offers Results within 15 Minutes
Trend Themes
1. Low-cost Healthcare Solutions - Opportunity for companies to develop low-cost healthcare solutions to help contain the spread of viruses and other diseases.
2. Fast and Effective Virus Testing - Opportunity for companies to develop and market fast, accurate virus testing products such as the Abbott BinaxNOW COVID-19 test.
3. Smart Health Apps - Opportunity for companies to develop smart health apps such as Abbott's Novice app, which can provide users with temporary health passes.
Industry Implications
1. Healthcare Technology - Companies in the healthcare technology industry can develop and market low-cost virus test kits, fast and effective virus testing products, and smart health apps.
2. Pharmaceuticals - Pharmaceutical companies can invest in the development of low-cost virus test kits and fast, accurate virus testing products.
3. E-commerce - Companies in the e-commerce industry can offer low-cost virus test kits and fast, effective virus testing products for online purchase and delivery.